GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (NAS:CDMOP.PFD) » Definitions » EBIT

CDMOP.PFD (Avid Bioservices) EBIT : $-26.81 Mil (TTM As of Oct. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Avid Bioservices EBIT?

Avid Bioservices's earnings before interest and taxes (EBIT) for the three months ended in Oct. 2024 was $-14.13 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Oct. 2024 was $-26.81 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Avid Bioservices's annualized ROC % for the quarter that ended in Oct. 2024 was -17.60%. Avid Bioservices's annualized ROC (Joel Greenblatt) % for the quarter that ended in Oct. 2024 was -25.18%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Avid Bioservices's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2024 was 76.16%.


Avid Bioservices EBIT Historical Data

The historical data trend for Avid Bioservices's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices EBIT Chart

Avid Bioservices Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.46 12.38 15.34 4.60 -22.59

Avid Bioservices Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.08 -6.18 -3.42 -3.08 -14.13

Competitive Comparison of Avid Bioservices's EBIT

For the Biotechnology subindustry, Avid Bioservices's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avid Bioservices's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avid Bioservices's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Avid Bioservices's EV-to-EBIT falls into.


;
;

Avid Bioservices EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-26.81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avid Bioservices  (NAS:CDMOP.PFD) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Avid Bioservices's annualized ROC % for the quarter that ended in Oct. 2024 is calculated as:

ROC % (Q: Oct. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jul. 2024 ) + Invested Capital (Q: Oct. 2024 ))/ count )
=-50.524 * ( 1 - 0% )/( (282.105 + 291.882)/ 2 )
=-50.524/286.9935
=-17.60 %

where

Note: The Operating Income data used here is four times the quarterly (Oct. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Avid Bioservices's annualized ROC (Joel Greenblatt) % for the quarter that ended in Oct. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Oct. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jul. 2024  Q: Oct. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-56.52/( ( (226.358 + max(-13.653, 0)) + (222.565 + max(-21.424, 0)) )/ 2 )
=-56.52/( ( 226.358 + 222.565 )/ 2 )
=-56.52/224.4615
=-25.18 %

where Working Capital is:

Working Capital(Q: Jul. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(20.962 + 29.196 + 5.872) - (19.999 + 37.659 + 12.025)
=-13.653

Working Capital(Q: Oct. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(18.411 + 28.073 + 4.803) - (9.251 + 51.671 + 11.789)
=-21.424

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Oct. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Avid Bioservices's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Oct. 2024 )
=-26.813/-35.204
=76.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avid Bioservices EBIT Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Avid Bioservices Business Description

Traded in Other Exchanges
N/A
Address
14191 Myford Road, Tustin, CA, USA, 92780
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.